Citrus fruits are essential sources of bioactive compounds with antioxidant properties, such as flavonoids. These polyphenolic compounds are divided into subclasses, in which flavanones are the most prominent.

Among them, naringenin and hesperidin are emerging compounds with anticancer potential, especially for breast cancer (BC).

Several mechanisms have been proposed, including the modulation of epigenetics, estrogen signaling, induction of cell death via regulation of apoptotic signaling pathways, and inhibition of tumor invasion and metastasis. However, this information is sparse in the literature and needs to be brought together to provide an overview of how naringenin and hesperidin can serve as therapeutic tools for drug development and as a successful co-adjuvant strategy against BC.

You can read about niclosamide. I read a study that showed that it inhibited human breast cancer cell growth under laboratory conditions. The authors of the study suggested that fenbendazole might have the potential to treat breast cancer, and it could also be used as an adjunct to chemotherapy.
If you are interested in using niclosamide to treat cancer, it is important to find a quality company that sells it, such as consider this . It is also important to talk to your doctor to discuss your options and consider the potential risks and benefits of this approach.